Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases

被引:105
|
作者
Wu, Xinyu [1 ,2 ]
Tian, Jie [2 ]
Wang, Shengjun [1 ,2 ]
机构
[1] Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China
[2] Jiangsu Univ, Sch Med, Dept Immunol, Jiangsu Key Lab Lab Med, Zhenjiang, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Th17; cells; IL-10; inflammation; immunosuppression; autoimmune diseases; REGULATORY T-CELLS; NONOBESE DIABETIC MICE; T(H)17 CELLS; C-MAF; TRANSCRIPTION FACTOR; TGF-BETA; IL-17; INTERLEUKIN-17; EXPRESSION; INDUCTION;
D O I
10.3389/fimmu.2018.01112
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Th17 cells are generally considered to be positive regulators of immune responses because they produce pro-inflammatory cytokines, including IL-17A, IL-17F, and IL-22. Cytokine production not only promotes accumulation of immune cells, such as macrophages, neutrophils and lymphocytes, at inflammatory sites but can also cause tissue pathologies. Conversely, certain Th17 cells can also negatively regulate immune responses by secreting immunosuppressive factors, such as IL-10; these cells are termed non-pathogenic Th17 cells. In this review, we summarize recent advances in the development and regulatory functions of non-pathogenic Th17 cells in autoimmune diseases.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Novel regulatory Th17 cells and regulatory B cells in modulating autoimmune diseases
    Singh, Bhagirath
    Summers, Kelly L.
    Kerfoot, Steven M.
    CELLULAR IMMUNOLOGY, 2019, 339 : 29 - 32
  • [32] STIM1-mediated calcium influx controls antifungal immunity and the metabolic function of non-pathogenic Th17 cells
    Kahlfuss, Sascha
    Kaufmann, Ulrike
    Concepcion, Axel R.
    Noyer, Lucile
    Raphael, Dimitrius
    Vaeth, Martin
    Yang, Jun
    Pancholi, Priya
    Maus, Mate
    Muller, James
    Kozhaya, Lina
    Khodadadi-Jamayran, Alireza
    Sun, Zhengxi
    Shaw, Patrick
    Unutmaz, Derya
    Stathopulos, Peter B.
    Feist, Cori
    Cameron, Scott B.
    Turvey, Stuart E.
    Feske, Stefan
    EMBO MOLECULAR MEDICINE, 2020, 12 (08)
  • [33] Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses
    Ma, Ke
    Chen, Xi
    Chen, Jia-Cheng
    Wang, Ying
    Zhang, Xi-meng
    Huang, Fan
    Zheng, Jun-Jiong
    Chen, Xiong
    Yu, Wei
    Cheng, Ke-Ling
    Feng, Yan-Qing
    Gu, Huai-yu
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (06) : 1151 - 1162
  • [34] Selectively targeting pathogenic TH17 cells
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2020, 19 (8) : 512 - 512
  • [35] The Pathogenic Subpopulation of Th17 Cells in Obesity
    Todosenko, Natalia
    Vulf, Maria
    Yurova, Kristina
    Skuratovskaia, Daria
    Khaziakhmatova, Olga
    Gazatova, Natalia
    Melashchenko, Olga
    Urazova, Olga
    Litvinova, Larisa
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (37) : 3924 - 3938
  • [36] Salt promotes pathogenic TH17 cells
    Olive Leavy
    Nature Reviews Immunology, 2013, 13 : 225 - 225
  • [37] Are Th17 cells in the gut pathogenic or protective?
    Symons, A.
    Budelsky, A. L.
    Towne, J. E.
    MUCOSAL IMMUNOLOGY, 2012, 5 (01) : 4 - 6
  • [38] Autoimmune thyroid diseases and Th17/Treg lymphocytes
    Shao, Shiying
    Yu, Xuefeng
    Shen, Liya
    LIFE SCIENCES, 2018, 192 : 160 - 165
  • [39] Th17 cells in airway diseases
    Traves, Suzanne L.
    Donnelly, Louise E.
    CURRENT MOLECULAR MEDICINE, 2008, 8 (05) : 416 - 426
  • [40] Th17 cells in autoimmune demyelinating disease
    Benjamin Matthew Segal
    Seminars in Immunopathology, 2010, 32 : 71 - 77